Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00245635 · ClinicalTrials.gov registry record · Phase 4
Fluoxetine in Pediatric Body Dysmorphic Disorder
A Phase 4 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 43
- Enrollment target
NCT00245635 is a Phase 4 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 43 participants.
The verdict
NCT00245635, a Phase 4 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 43 participants
- Enrollment target
Study Summary
This trial will study the effectiveness of the medication fluoxetine for children and adolescents ages 16 and younger with BDD who qualify.
Interventions
- DRUG Placebo
- DRUG Fluoxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2004-11 |
| Est. Completion | 2012-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00245635
The ClinicalTrials.gov registry entry for NCT00245635 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00245635 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00245635 about?
NCT00245635 is a clinical study titled "Fluoxetine in Pediatric Body Dysmorphic Disorder". This trial will study the effectiveness of the medication fluoxetine for children and adolescents ages 16 and younger with BDD who qualify.
What is the current status of trial NCT00245635?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 43 participants. The study started on 2004-11. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00245635?
The interventions under investigation include: Placebo (DRUG), Fluoxetine (DRUG).
Who is sponsoring clinical trial NCT00245635?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.